Cutaneous melanoma and lung adenocarcinoma contained the largest number of patients with an approved actionable marker detected by all sequencing types which was due to the high prevalence of BRAF V600 hotspot and EGFR mutations, respectively. The gene discussed is BRAF; the disease is cutaneous melanoma.